330 related articles for article (PubMed ID: 19891494)
1. Interplay of transporters and enzymes in drug and metabolite processing.
Pang KS; Maeng HJ; Fan J
Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
[TBL] [Abstract][Full Text] [Related]
2. Interplay of transporters and enzymes in the Caco-2 cell monolayer: I. effect of altered apical secretion.
Fan J; Maeng HJ; Pang KS
Biopharm Drug Dispos; 2010 May; 31(4):215-27. PubMed ID: 20437461
[TBL] [Abstract][Full Text] [Related]
3. Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis.
Tam D; Sun H; Pang KS
Drug Metab Dispos; 2003 Oct; 31(10):1214-26. PubMed ID: 12975330
[TBL] [Abstract][Full Text] [Related]
4. The roles of transporters and enzymes in hepatic drug processing.
Liu L; Pang KS
Drug Metab Dispos; 2005 Jan; 33(1):1-9. PubMed ID: 15466164
[TBL] [Abstract][Full Text] [Related]
5. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
Sun H; Pang KS
Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interplay of phase II metabolism and transport: a theoretical study.
Wu B
J Pharm Sci; 2012 Jan; 101(1):381-93. PubMed ID: 21905031
[TBL] [Abstract][Full Text] [Related]
7. Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.
Zhang L; Zhang Y; Huang SM
Mol Pharm; 2009; 6(6):1766-74. PubMed ID: 19839641
[TBL] [Abstract][Full Text] [Related]
8. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
Soars MG; Webborn PJ; Riley RJ
Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
[TBL] [Abstract][Full Text] [Related]
10. The pivotal role of hepatocytes in drug discovery.
Soars MG; McGinnity DF; Grime K; Riley RJ
Chem Biol Interact; 2007 May; 168(1):2-15. PubMed ID: 17208208
[TBL] [Abstract][Full Text] [Related]
11. A catenary model to study transport and conjugation of baicalein, a bioactive flavonoid, in the Caco-2 cell monolayer: demonstration of substrate inhibition.
Sun H; Zhang L; Chow EC; Lin G; Zuo Z; Pang KS
J Pharmacol Exp Ther; 2008 Jul; 326(1):117-26. PubMed ID: 18385448
[TBL] [Abstract][Full Text] [Related]
12. Use of clearance concepts and modeling techniques in the prediction of metabolic drug-drug interactions.
Ito K; Sugiyama Y
Trends Pharmacol Sci; 2010 Aug; 31(8):351-5. PubMed ID: 20542578
[TBL] [Abstract][Full Text] [Related]
13. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
14. An integrated approach to model hepatic drug clearance.
Liu L; Pang KS
Eur J Pharm Sci; 2006 Nov; 29(3-4):215-30. PubMed ID: 16806855
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.
Pang KS
Drug Metab Dispos; 1995 Feb; 23(2):166-77. PubMed ID: 7736907
[TBL] [Abstract][Full Text] [Related]
16. Disparity in intestine disposition between formed and preformed metabolites and implications: a theoretical study.
Sun H; Pang KS
Drug Metab Dispos; 2009 Jan; 37(1):187-202. PubMed ID: 18948379
[TBL] [Abstract][Full Text] [Related]
17. Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes.
Lam JL; Benet LZ
Drug Metab Dispos; 2004 Nov; 32(11):1311-6. PubMed ID: 15483198
[TBL] [Abstract][Full Text] [Related]
18. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
Jeong EJ; Lin H; Hu M
J Pharmacol Exp Ther; 2004 Jul; 310(1):376-85. PubMed ID: 15020665
[TBL] [Abstract][Full Text] [Related]
19. Saturable metabolism and its relationship to toxicity.
Andersen ME
Crit Rev Toxicol; 1981 May; 9(2):105-50. PubMed ID: 7026174
[TBL] [Abstract][Full Text] [Related]
20. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
